A Molecular Signature of the Nottingham Prognostic Index in Breast Cancer

Cancer Research

Volumn 64, Issue 9, 2004, Pages 2962-2968

  Yu, Kun ^a   Lee, Chee How ^a   Tan, Puay Hoon ^b   Hong, Ga Sze ^a   Wee, Siew Bok ^a   Wong, Chow Yin ^a   Tan, Patrick ^a,c  

^a DIVISION OF MEDICAL ONCOLOGY   (Singapore)

^b Defence Medical and Environmental Research Institute   (Singapore)

^c Department of Pathology ^*  (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR;

ARTICLE; BREAST CANCER; CANCER STAGING; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; NOTTINGHAM PROGNOSTIC INDEX; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

BREAST NEOPLASMS; CLUSTER ANALYSIS; GENE EXPRESSION PROFILING; HUMANS; NEOPLASM STAGING; PROGNOSIS; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; SURVIVAL RATE;

EID: 2342476480     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-03-2430     Document Type: Article

References (20)

1. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer: I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 1991;19:403-10.
2. Galea MH, Blamey RW, Elston CW, Ellis IO. The Nottingham prognostic index in primary breast cancer. Breast Cancer Res Treat 1992;22:207-19.
3. Balslev I, Axelsson CK, Zedeler K, Ramussen BB, Carstensen B, Mouridsen HT. The Nottingham prognostic index applied to 9,419 patients from the studies of the Danish Breast Cancer Cooperative Group (DBCG). Breast Cancer Res Treat 1994;32:281-90.
4. Sauerbrei W, Hubner K, Schmoor C, Schumacher M. Validation of existing and development of new prognostic classification schemes in node negative breast cancer. Breast Cancer Res Treat 1997;42:149-63.
5. Gilchrist K, Kalish WL, Gould VE, et al. Interobserver reproducibility of histopathological features in stage II breast cancer. An ECOG study Breast Cancer Res Treat 1985;5:3-10.
6. Buettner P, Garbe C, Guggenmoos-Holzmann I. Problems in defining cutoff points of continuous prognostic factors: Example of tumor thickness in primary cutaneous melanoma J Clin Epidemiol 1997;50:1201-10.
7. Perou CM, Sorlie T, Eisen MB, et al. Molecular portraits of human breast tumors. Nature (Lond) 2000;406:747-52.
8. Gruvberger S, Ringner M, Chen Y, et al. Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns. Cancer Res 2001;61:5979-84.
9. Sotiriou C, Neo SY, McShane LM, et al. Breast cancer classification and prognosis based on gene expression profiles from a population-based study. Proc Natl Acad Sci USA 2003;100:10393-8.
10. van't Veer LJ, Dai H, van de Vijver MJ, et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature (Lond) 2002;415:530-6.
11. West M, Blanchette C, Dressman H, et al. Predicting the clinical status of human breast cancer by using gene expression profiles. Proc Natl Acad Sci USA 2001;98:11462-7.
12. Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 1998;95:14863-8.
13. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 2001;98:5116-21.
14. Golub TR, Slonim DK, Tamayo P, et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science (Wash D C) 1999;286:531-7.
15. Sorlie TC, Perou M, Tibshirani R, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 2001;98:10869-74.
16. Martin KJ, Kritzman BM, Price LM, et al. Linking gene expression patterns to therapeutic groups in breast cancer. Cancer Res 2000;60:2232-8.
17. Sundquist M, Thorstenson S, Brudin L, Nordenskjold B. Applying the Nottingham prognostic index to a Swedish breast cancer population. Breast Cancer Res Treat 1999;53:1-8.
18. Barbareschi M, Caffo O, Veronese S, et al. Bcl-2 and p53 expression in node-negative breast carcinoma: a study with long-term follow-up. Hum Pathol 1996;27:1149-55.
19. Frkovic-Grazio, S, Bracko M. Long term prognostic value of Nottingham histological grade and its components in early (pT1NOM0) breast carcinoma. J Clin Pathol 2002;55:88-92.
20. Ramaswamy S, Ross KN, Lander ES, Golub TR. A molecular signature of metastasis in primary solid tumors. Nat Genet 2003;33:49-54.